Suppr超能文献

三苯基-1,2,3-三唑类化合物的设计、合成及抗增殖活性比较分析。

Design, synthesis and comparative analysis of triphenyl-1,2,3-triazoles as anti-proliferative agents.

机构信息

Bio-organic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi, 110025, India.

PK-PD Toxicology & Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India.

出版信息

Eur J Med Chem. 2020 Dec 1;207:112813. doi: 10.1016/j.ejmech.2020.112813. Epub 2020 Sep 9.

Abstract

Herein, a series of triaryl-1,2,3-triazoles, in order to check cytotoxicity on breast cancer cell lines have been synthesized with pendent benzyl ring to mimic the phenolic A ring of Tamoxifene. The biological results indicated that most of the compounds possessed comparative anti-proliferative activities in both ER + ve (MCF-7) and ER-ve (MDA-MB-231) breast cancer cell lines. Among synthesized derivatives, five compounds 8f, 8i, 8j, 8n and 8p showed anti-proliferative activities at <5 μM against MCF-7 cell line and three compounds 8e, 8f and 8j show IC value greater than 30 μM in FR-2 cells (normal cell). Moreover, to understand the mechanistic behavior of the selective compound 8f, various studies performed viz. surface morphological changes by bright field microscopic examination, nuclear morphological alteration by DAPI staining, measurement of intracellular ROS level and determination of change in mitochondrial membrane potential. It was observed that, the selective compound 8f associated with higher ROS generation along with decrease in mitochondrial membrane potential in addition to surface and nuclear morphological alterations such as reduction in number and shrinkage of cells coupled with nuclear blabbing indicating sign of apoptosis. Further, molecular docking study in comparison to tamoxifen was also carried out to investigate the interaction of 8f with ER-α which favors its possible mode of anticancer action.

摘要

本文合成了一系列带有苄基侧链的三芳基-1,2,3-三唑,以模拟他莫昔芬的酚 A 环,用于检测对乳腺癌细胞系的细胞毒性。生物实验结果表明,大多数化合物对 ER+ve(MCF-7)和 ER-ve(MDA-MB-231)乳腺癌细胞系均具有相当的抗增殖活性。在所合成的衍生物中,化合物 8f、8i、8j、8n 和 8p 对 MCF-7 细胞系的增殖活性小于 5μM,化合物 8e、8f 和 8j 在 FR-2 细胞(正常细胞)中的 IC 值大于 30μM。此外,为了了解选择性化合物 8f 的作用机制,进行了各种研究,例如通过明场显微镜检查观察表面形态变化、通过 DAPI 染色观察核形态改变、测量细胞内 ROS 水平以及确定线粒体膜电位的变化。结果表明,选择性化合物 8f 与更高的 ROS 生成相关,同时伴随着线粒体膜电位的降低,此外还观察到细胞表面和核形态的改变,如细胞数量减少和缩小,以及核分裂,表明凋亡的迹象。进一步,与他莫昔芬相比,还进行了分子对接研究,以研究 8f 与 ER-α 的相互作用,这有利于其可能的抗癌作用模式。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验